Delivery Order SPE2DB20D3101-SPE2DB24FQUP0
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The fixed-price delivery order, valued at $2,705.64, has a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award, valued at $1,313.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, a pharmaceutical product used to treat respiratory conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,348.16, is for the delivery of Spiriva Respimat 2.5 MCG INH 4GM, a respiratory medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,564,071,820 units of Spiriva Respimat 1.25 mcg inhalation medication, valued at $1,433.04. The award is a delivery order under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2025....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Spiriva Respimat 2.5 mcg inhalers. The $3,578.37 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that supports U.S. military healthcare. The contract has an ultimate completion date of September 14, 2022 and was awarded on September 13, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a...
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, valued at $1,102.08. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has a ceiling value of $1,102.08 and is a delivery order under an Indefinite Delivery Contract (IDC) held...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,192.92 firm fixed-price delivery order is for the supply of Spiriva Respimat 2.5 MCG Inhalation medication, with a period of performance ending on July 24, 2023. The contract is not designated as a set-aside. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,177.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Spiriva Respimat 1.25 MCG INH 4GM, a pharmaceutical product used for respiratory conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 19, 2023. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,054.28 firm fixed-price delivery order is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with an ultimate completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,294.68, is for the delivery of Spiriva Respimat 2.5 MCG inhalation medication. The award is a firm fixed-price Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQUP0Delivery Order
This federal contract award, valued at $1,715.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Spiriva Respimat 1.25 MCG inhalation medication and is a firm fixed-price delivery order with a completion date of November 15, 2023. The award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/14/23 |